462 related articles for article (PubMed ID: 16264162)
21. A decision rule for sequential monitoring of clinical trials with a primary and supportive outcome.
Zhao Y; Grambsch PM; Neaton JD
Clin Trials; 2007; 4(2):140-53. PubMed ID: 17456513
[TBL] [Abstract][Full Text] [Related]
22. Early Termination of Acute Stroke Randomized Controlled Trials Published Between 2013 and 2020: A Systematic Review.
Strong B; Oostema JA; Nikroo N; Hussain M; Reeves MJ
Circ Cardiovasc Qual Outcomes; 2021 Dec; 14(12):e007995. PubMed ID: 34932376
[TBL] [Abstract][Full Text] [Related]
23. Randomised trials with provision for early stopping for benefit (or harm): The impact on the estimated treatment effect.
Walter SD; Guyatt GH; Bassler D; Briel M; Ramsay T; Han HD
Stat Med; 2019 Jun; 38(14):2524-2543. PubMed ID: 30887553
[TBL] [Abstract][Full Text] [Related]
24. Comparison of cellulose, modified cellulose and synthetic membranes in the haemodialysis of patients with end-stage renal disease.
MacLeod A; Daly C; Khan I; Vale L; Campbell M; Wallace S; Cody J; Donaldson C; Grant A
Cochrane Database Syst Rev; 2001; (3):CD003234. PubMed ID: 11687058
[TBL] [Abstract][Full Text] [Related]
25. Inefficacy interim monitoring procedures in randomized clinical trials: the need to report.
Korn EL; Freidlin B
Am J Bioeth; 2011 Mar; 11(3):2-10. PubMed ID: 21400374
[TBL] [Abstract][Full Text] [Related]
26. Initiation and continuation of randomized trials after the publication of a trial stopped early for benefit asking the same study question: STOPIT-3 study design.
Prutsky GJ; Domecq JP; Erwin PJ; Briel M; Montori VM; Akl EA; Meerpohl JJ; Bassler D; Schandelmaier S; Walter SD; Zhou Q; Coello PA; Moja L; Walter M; Thorlund K; Glasziou P; Kunz R; Ferreira-Gonzalez I; Busse J; Sun X; Kristiansen A; Kasenda B; Qasim-Agha O; Pagano G; Pardo-Hernandez H; Urrutia G; Murad MH; Guyatt G
Trials; 2013 Oct; 14():335. PubMed ID: 24131702
[TBL] [Abstract][Full Text] [Related]
27. Overestimation of benefit when clinical trials stop early: a simulation study.
Liu S; Garrison SR
Trials; 2022 Sep; 23(1):747. PubMed ID: 36064448
[TBL] [Abstract][Full Text] [Related]
28. Comparison of Registered and Reported Outcomes in Randomized Clinical Trials Published in Anesthesiology Journals.
Jones PM; Chow JTY; Arango MF; Fridfinnson JA; Gai N; Lam K; Turkstra TP
Anesth Analg; 2017 Oct; 125(4):1292-1300. PubMed ID: 28704247
[TBL] [Abstract][Full Text] [Related]
29. Recruitment and retention of participants in randomised controlled trials: a review of trials funded and published by the United Kingdom Health Technology Assessment Programme.
Walters SJ; Bonacho Dos Anjos Henriques-Cadby I; Bortolami O; Flight L; Hind D; Jacques RM; Knox C; Nadin B; Rothwell J; Surtees M; Julious SA
BMJ Open; 2017 Mar; 7(3):e015276. PubMed ID: 28320800
[TBL] [Abstract][Full Text] [Related]
30. Reporting of conflicts of interest in meta-analyses of trials of pharmacological treatments.
Roseman M; Milette K; Bero LA; Coyne JC; Lexchin J; Turner EH; Thombs BD
JAMA; 2011 Mar; 305(10):1008-17. PubMed ID: 21386079
[TBL] [Abstract][Full Text] [Related]
31. Stopping a trial early in oncology: for patients or for industry?
Trotta F; Apolone G; Garattini S; Tafuri G
Ann Oncol; 2008 Jul; 19(7):1347-1353. PubMed ID: 18304961
[TBL] [Abstract][Full Text] [Related]
32. Reported use of data monitoring committees in the main published reports of randomized controlled trials: a cross-sectional study.
Sydes MR; Altman DG; Babiker AB; Parmar MK; Spiegelhalter DJ;
Clin Trials; 2004 Feb; 1(1):48-59. PubMed ID: 16281462
[TBL] [Abstract][Full Text] [Related]
33. The fragility of statistically significant findings from randomized trials in spine surgery: a systematic survey.
Evaniew N; Files C; Smith C; Bhandari M; Ghert M; Walsh M; Devereaux PJ; Guyatt G
Spine J; 2015 Oct; 15(10):2188-97. PubMed ID: 26072464
[TBL] [Abstract][Full Text] [Related]
34. Randomized controlled trials and neurosurgery: the ideal fit or should alternative methodologies be considered?
Mansouri A; Cooper B; Shin SM; Kondziolka D
J Neurosurg; 2016 Feb; 124(2):558-68. PubMed ID: 26315006
[TBL] [Abstract][Full Text] [Related]
35. Systematic reviewers neglect bias that results from trials stopped early for benefit.
Bassler D; Ferreira-Gonzalez I; Briel M; Cook DJ; Devereaux PJ; Heels-Ansdell D; Kirpalani H; Meade MO; Montori VM; Rozenberg A; Schünemann HJ; Guyatt GH
J Clin Epidemiol; 2007 Sep; 60(9):869-73. PubMed ID: 17689802
[TBL] [Abstract][Full Text] [Related]
36. Eligibility criteria of randomized controlled trials published in high-impact general medical journals: a systematic sampling review.
Van Spall HG; Toren A; Kiss A; Fowler RA
JAMA; 2007 Mar; 297(11):1233-40. PubMed ID: 17374817
[TBL] [Abstract][Full Text] [Related]
37. Assumptions of expected benefits in randomized phase III trials evaluating systemic treatments for cancer.
Gan HK; You B; Pond GR; Chen EX
J Natl Cancer Inst; 2012 Apr; 104(8):590-8. PubMed ID: 22491345
[TBL] [Abstract][Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
